Abstract:Fluorine-containing groups can modulate the physicochemical and biological properties of organic molecules. Consequently, the synthesis of fluorinated organic molecules has attracted considerable attention in the field of pharmaceuticals, agrochemicals and material sciences. Among fluorine-containing groups, the trifluoromethylthio group has the highest Hansch's hydrophobicity parameter and remarkable electron-withdrawing character. The incorporation of a trifluoromethylthio group into organic molecules can significantly enhance their membrane permeability and metabolic stability because of its high lipophilicity and strong electron-withdrawing effect. As a result, various methods have been involved to synthesize SCF3-containing compounds using electrophilic or nucleophilic trifluoromethylthio reagents. On the other hand, the chirality of pharmaceutical molecules has an important effect on their properties, and different stereoisomers of a pharmaceutical molecules always have dramatically different pharmaceutical activities. Thus, the asymmetric trifluoromethylthiolation of organic molecules is of growing interest in recent years. Up to now, this field is still in the stage of initial development. In this perspective article, we will briefly summarize the methods of asymmetric trifluoromethylthiolation of organic molecules that have been reported so far. Two different strategies including the use of electrophilic trifluoromethylthiolating reagents and the use of trifluoromethylthio-containing building blocks will be introduced. Employing electrophilic trifluoromethylthiolating reagents, the enantioselective trifluoromethylthiolation of beta-ketoesters, oxindoles as well as alkenes have been developed using Cinchona alkaloid, copper(II) or indane-based chiral sulfide/selenide as the catalyst. Alternatively, using trifluoromethylthiolated building blocks is another approach to establish chiral centers bearing the trifluoromethylthio group. In this approach, an asymmetric trifluoromethylthiolation via enantioselective [2,3]-sigmatropic rearrangement of a sulfonium ylide generated from SCF3-containing sulfide and metal carbene has been disclosed using chiral Rh(II) and Cu(I) as the catalyst. Finally, we will discuss the challenges of the asymmetric trifluoromethylthiolation of organic molecules in the future.

Recent advances in the trifluoromethylation methodology and new CF3-containing drugs

Recent Advances of the Construction of Trifluoromethylated Quaternary Carbon Center

Recent advances in trifluoromethylation of organic compounds using Umemoto's reagents

Recent advances in trifluoroethylation reaction

Trifluoromethylsulfinyl Compounds: Recent Synthetic Approaches and Future Perspectives

A straightforward access to trifluoromethylated natural products through late-stage functionalization

A Unified Flow Strategy for the Preparation and Use of Trifluoromethyl-heteroatom Anions

Recent Advance in Asymmetric Trifluoromethylthiolation

Recent Developments in the Trifluoromethylation of Alkynes

Trifluoromethyl N -acylhydrazones: A versatile trifluoromethyl building blocks for construction of trifluoromethylated nitrogen-containing compounds

Defluorinative Functionalization Approach led by Difluoromethyl Anion Chemistry

FDA-Approved Trifluoromethyl Group-Containing Drugs: A Review of 20 Years

Advances in the Transition Metal‐Free C‐H Trifluoromethylation

Recent Advancements in Trifluoromethylation Strategies for Indoles, Oxindoles and Indolines

Recent Advances in the Synthesis of N‐fluoroalkyl Amides/Sulfonamides and Their Carbonyl/Sulfonyl Derivatives

Difluoroethylation Reactions of Organic Compounds

Fluorination in Medicinal Chemistry: Methods, Strategies, and Recent Developments

Transition‐Metal‐Catalyzed Reactions Involving Trifluoro Diazo Compounds and Their Surrogates

Recent Advances in Transition-Metal-catalyzed Incorporation of Fluorine-Containing Groups